Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01545674 · ClinicalTrials.gov registry record
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
A clinical trial, sponsored by Natera.
- Terminated
- Registry status
- 937
- Enrollment target
NCT01545674: Clinical Trial study, sponsored by Natera.
NCT01545674 is a clinical trial that was terminated before completion, run by Natera. The registered enrollment target is 937 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01545674 was terminated before completion, sponsored by Natera.
- TERMINATED
- Registry status
- 937 participants
- Enrollment target
Study Summary
This prospective blinded study will assess the diagnostic capability of an informatics enhanced SNP based technology (Parental Support) to identify pregnant women who are carrying a fetus with an aneuploidy from fee floating DNA in the maternal blood.
Primary Outcome
The primary objective is to determine the diagnostic capability of the test to detect autosomal aneuploidy (chromosomes 13, 18, 21) and sex aneuploidy (X and Y).
Interventions
- PROCEDURE Blood Draw
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 937 participants |
| Start Date | 2012-01 |
| Est. Completion | 2023-03 |
Why NCT01545674 stopped before completion
NCT01545674 is an observational study that tracks outcomes without assigning an intervention. The registered 937 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Blood Draw is the first listed.
NCT01545674 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01545674 about?
NCT01545674 is a clinical study titled "Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial". This prospective blinded study will assess the diagnostic capability of an informatics enhanced SNP based technology (Parental Support) to identify pregnant women who are carrying a fetus with an aneuploidy from fee floating DNA in the maternal blood.
What is the current status of trial NCT01545674?
This trial is currently terminated. The enrollment target is 937 participants. The study started on 2012-01. Estimated completion is 2023-03.
What interventions are being tested in trial NCT01545674?
The interventions under investigation include: Blood Draw (PROCEDURE).
Who is sponsoring clinical trial NCT01545674?
This trial is sponsored by Natera, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05519007 · 936 participants · NA
Rate of Total Joint Infection 90-day After Surgery Following Irrigation With Next Science No-Rinse Solution vs SOC Alone
- NCT03075696 · 940 participants · Phase 1
A Dose Escalation Study of Glofitamab (RO7082859) as a Single Agent and in Combination With Obinutuzumab, Administered After a Fixed, Single Pre-treatment Dose of Obinutuzumab in Participants With Relapsed/Refractory B-cell Non-hodgkin's Lymphoma
- NCT06855277 · 940 participants · Phase 3
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
- NCT04626635 · 933 participants · Phase 1
A Trial to Find Out How Safe REGN7075 is and How Well it Works in Combination With Cemiplimab for Adult Participants With Advanced Cancers
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia